ReviewFrontiers in pharmacology2026

Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications.

Meidan Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.